Vergoeding 2019-2023 voor ATC-subgroep L04AH : Mtor-kinaseremmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L04AH01 Sirolimus (Rapamune ®) | 1.481.800 | 1.455.000 | 1.472.000 | 1.707.900 | 1.820.500 |
| L04AH02 Everolimus (Certican ®) | 4.987.000 | 4.785.200 | 4.756.800 | 5.520.900 | 5.598.500 |
| Totaal | 6.468.800 | 6.240.200 | 6.228.800 | 7.228.800 | 7.419.000 |